Brought to you by 
IPO nets $50.2mm for Complete Genomics
27 Apr 2012
Executive Summary
Four months after its S-1 filing, large-scale human genome sequencing start-up Complete Genomics Inc. netted $50.2mm in an IPO of 6mm common shares at $9. The company announced last month that it had hoped to get between $12-14 per share.
Deal Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Services
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IPO nets $50.2mm for Complete Genomics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice